AbbVie Inc. is 275.4x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($397.12 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLS | ABBV |
|---|---|---|
| Market cap | $1.44 B | $397.12 B |
| US-listed rank | #2371 | #30 |
| Revenue (latest FY) | $0.00 | $61.16B |
| Net income (latest FY) | -$26.86M | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 1,262 | 1,008 |
AbbVie Inc. is 275.4x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($397.12 B vs $1.44 B).
Full pages: SELLAS Life Sciences Group, Inc. and AbbVie Inc., or browse the full rankings.